Financials

  • Market Capitalization 1.42 B
  • Employee 175
  • Founded 1994
  • CEO N/A
  • Website www.omeros.com
  • Headquarter Washington, United States
  • FIGI BBG000JLP4B4
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-343.5
ratio cours/chiffre d'affaires
1 222.86

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2146
SNDX
Syndax Pharmaceuticals, Inc. - Common Stock
16.48 USD-3.00%-7.36%-9.75%+1.92%1.47 B USD
2164
TSHA
Taysha Gene Therapies, Inc. - Common Stock
4.20 USD-6.46%-5.83%-16.00%-13.93%1.37 B USD
2171
AAPG
Ascentage Pharma Group International - American Depository Shar
15.31 USD+3.80%+3.80%-6.25%-38.76%1.43 B USD
2193
INBX
Inhibrx Biosciences, Inc. - Common Stock
94.37 USD-0.67%-1.65%-13.50%+17.11%1.39 B USD

Nouvelles